• No se han encontrado resultados

Historia campesina Luis Leonel Oliveros Rosales

In document Médicos escritores latinoamericanos (página 68-70)

1. Boehmer von H (2004) Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development. Adv Immunol 84:201–238.

2. Xiong N, Raulet DH (2007) Development and selection of γδ T cells. Immunol Rev

215:15–31.

3. Bonneville M, O'brien RL, Born WK (2010) γδ T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 10:467–478.

4. Lanier LL (2013) Shades of grey—the blurring view of innate and adaptive immunity. Nat Rev Immunol 13:73–74.

5. van der Merwe PA, Davis SJ (2003) Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 21:659–684.

6. Marrack P, Rubtsova K, Scott-Browne J, Kappler JW (2008) T cell receptor specificity for major histocompatibility complex proteins. Current opinion in immunology 20:203–207. 7. Bjorkman PJ et al. (1987) Structure of the human class I histocompatibility antigen, HLA-

A 2. Nature 329:506–512.

8. Jardetzky TS et al. (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711–718.

9. Garcia KC et al. (1996) An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209–219.

10. Stern LJ et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215–221.

11. Zhu J, Yamane H, Paul WE (2010) Differentiation of Effector CD4 T Cell Populations *.

Annu Rev Immunol 28:445–489.

12. Barry M, Bleackley RC (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2:401–409.

13. Zhang N, Bevan MJ (2011) CD8+ T Cells: Foot Soldiers of the Immune System.

Immunity 35:161–168.

14. Bassing CH, Swat W, Alt FW (2002) The mechanism and regulation of chromosomal V(D)J recombination. Cell 109:S45–S55.

15. Schatz DG, Swanson PC (2011) V(D)J Recombination: Mechanisms of Initiation. Annu Rev Genet 45:167–202.

16. Helmink BA, Sleckman BP (2012) The Response to and Repair of RAG-Mediated DNA Double-Strand Breaks. Annu Rev Immunol 30:175–202.

17. Krangel MS (2009) Mechanics of T cell receptor gene rearrangement. Current opinion in immunology 21:133–139.

18. Love PE, Bhandoola A (2011) Signal integration and crosstalk during thymocyte migration and emigration. Nat Rev Immunol 11:469–477.

19. Carpenter AC, Bosselut R (2010) Decision checkpoints in the thymus. Nat Immunol

11:666–673.

20. Rothenberg EV, Moore JE, Yui MA (2008) Launching the T-cell-lineage developmental programme. Nat Rev Immunol 8:9–21.

21. Bell JJ, Bhandoola A (2008) The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 452:764–767.

22. Kreslavsky T, Gleimer M, Garbe AI, Boehmer von H (2010) αβ versus γδ fate choice: counting the T-cell lineages at the branch point. Immunol Rev 238:169–181.

23. Kreslavsky T et al. (2012) β-Selection-Induced Proliferation Is Required for αβ T Cell Differentiation. Immunity 37:840–853.

24. Starr TK, Jameson SC, Hogquist KA (2003) Positive and Negative Selection of T Cells.

Annu Rev Immunol 21:139–176.

25. Singer A, Adoro S, Park J-H (2008) Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol 8:788–801.

26. Cyster JG, Schwab SR (2012) Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs. Annu Rev Immunol 30:69–94.

27. Murali-Krishna K et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177–187.

28. Kaech SM, Hemby S, Kersh E, Ahmed R (2002) Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837–851.

29. Yamane H, Paul WE (2012) Memory CD4+ T Cells: fate determination, positive feedback and plasticity. Cell Mol Life Sci 69:1577–1583.

30. Wherry EJ et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4:225–234.

31. D'Argenio DA, Wilson CB (2010) A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design. Immunity 33:437–440.

32. Bendelac A, Matzinger P, Seder RA, Paul WE, Schwartz RH (1992) Activation events during thymic selection. J Exp Med 175:731–742.

33. Sawada S, Scarborough JD, Killeen N, Littman DR (1994) A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77:917–929.

34. Zou YR et al. (2001) Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat Genet 29:332–336.

35. Taniuchi I et al. (2002) Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621–633.

36. Egawa T, Tillman RE, Naoe Y, Taniuchi I, Littman DR (2007) The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J Exp Med 204:1945–1957.

37. Setoguchi R et al. (2008) Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319:822–825.

38. Naito T, Tanaka H, Naoe Y, Taniuchi I (2011) Transcriptional control of T-cell development. Int Immunol 23:661–668.

39. Grueter B et al. (2005) Runx3 regulates integrin αE/CD103 and CD4 expression during

development of CD4-/CD8+ T cells. J Immunol 175:1694-1705.

40. Keefe R, Dave V, Allman D, Wiest D, Kappes DJ (1999) Regulation of lineage commitment distinct from positive selection. Science 286:1149–1153.

41. He X et al. (2005) The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment. Nature 433:826–833.

42. Sun G et al. (2005) The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol 6:373–381.

43. Bosselut R, Guinter TI, Sharrow SO, Singer A (2003) Unraveling a Revealing Paradox: Why Major Histocompatibility Complex I-signaled Thymocytes “Paradoxically” Appear as CD4+8lo Transitional Cells During Positive Selection of CD8+ T Cells. J Exp Med

197:1709–1719.

44. Liu X, Bosselut R (2004) Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat Immunol 5:280–288.

45. Park J-H et al. (2010) Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol 11:257–264.

46. Adoro S et al. (2012) Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J 31:366–377.

47. Robey EA et al. (1991) Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage. Cell 64:99–107.

48. Rothenberg EV (2014) Transcriptional Control of Early T and B Cell Developmental Choices. Annu Rev Immunol 32:283–321.

49. Holmberg J, Perlmann T (2012) Maintaining differentiated cellular identity. Nature Reviews Genetics 13:429–439.

50. He X et al. (2008) CD4-CD8 Lineage Commitment Is Regulated by a Silencer Element at the ThPOK Transcription-Factor Locus. Immunity 28:346–358.

51. Wang L et al. (2008) The Zinc Finger Transcription Factor Zbtb7b Represses CD8- Lineage Gene Expression in Peripheral CD4+ T Cells. Immunity 29:876–887.

52. Muroi S et al. (2008) Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat Immunol 9:1113–1121.

53. Egawa T, Littman DR (2008) ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat Immunol

9:1131–1139.

54. Wildt KF et al. (2007) The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer. J Immunol 179:4405–4414. 55. Ellmeier W, Sunshine MJ, Losos K, Hatam F, Littman DR (1997) An enhancer that

directs lineage-specific expression of CD8 in positively selected thymocytes and mature T cells. Immunity 7:537–547.

56. Ellmeier W, Sunshine MJ, Losos K, Littman DR (1998) Multiple developmental stage- specific enhancers regulate CD8 expression in developing thymocytes and in thymus- independent T cells. Immunity 9:485–496.

57. Hostert A et al. (1997) A region in the CD8 gene locus that directs expression to the mature CD8 T cell subset in transgenic mice. Immunity 7:525–536.

58. Hostert A et al. (1998) Hierarchical interactions of control elements determine CD8α

gene expression in subsets of thymocytes and peripheral T cells. Immunity 9:497–508. 59. Rui J, Liu H, Zhu X, Cui Y, Liu X (2012) Epigenetic silencing of CD8 genes by ThPOK-

mediated deacetylation during CD4 T cell differentiation. J Immunol 189:1380–1390. 60. Pai S-Y et al. (2003) Critical roles for transcription factor GATA-3 in thymocyte

development. Immunity 19:863–875.

61. Wang L et al. (2008) Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4+ T cells. Nat Immunol 9:1122–1130.

62. Aliahmad P, Kaye J (2008) Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 205:245–256.

63. Sakaguchi S et al. (2010) The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes.

Nat Immunol 11:442–448.

64. Boucheron N et al. (2014) CD4(+) T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2. Nat Immunol 15:439–448.

65. Taniuchi I, Ellmeier W (2011) Transcriptional and Epigenetic Regulation of CD4/CD8 Lineage Choice. Adv Imm 110:71-110.

66. Kim VN, Han J, Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10:126–139.

67. Carthew RW, Sontheimer EJ (2009) Origins and Mechanisms of miRNAs and siRNAs.

Cell 136:642–655.

68. Kozomara A, Griffiths-Jones S (2013) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68–D73.

69. Friedman RC, Farh KKH, Burge CB, Bartel DP (2008) Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 19:92–105.

70. Volpe TA (2002) Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi. Science 297:1833–1837.

71. Grewal SIS, Jia S (2007) Heterochromatin revisited. Nature Reviews Genetics 8:35–46. 72. Djupedal I, Ekwall K (2009) Epigenetics: heterochromatin meets RNAi. Cell Res 19:282–

295.

73. Fukagawa T et al. (2004) Dicer is essential for formation of the heterochromatin structure in vertebrate cells. Nat Cell Biol 6:784–791.

74. Kanellopoulou C et al. (2005) Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19:489–501.

75. Watanabe T et al. (2008) Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 453:539–543.

76. Tam OH et al. (2008) Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 453:534–538.

77. Song R et al. (2011) Male germ cells express abundant endogenous siRNAs. Proc Natl Acad Sci USA 108:13159–13164.

78. Zhang H, Zhu J-K (2011) RNA-directed DNA methylation. Current Opinion in Plant Biology 14:142–147.

79. Cobb BS et al. (2005) T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 201:1367–1373.

80. Muljo SA et al. (2005) Aberrant T cell differentiation in the absence of Dicer. J Exp Med

202:261–269.

81. Cobb BS et al. (2006) A role for Dicer in immune regulation. J Exp Med 203:2519–2527. 82. Chong MMW, Rasmussen JP, Rudensky AY, Littman DR (2008) The RNAseIII enzyme

Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med

205:2005–2017.

83. Liston A, Lu L-F, O'Carroll D, Tarakhovsky A, Rudensky AY (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205:1993–2004. 84. Zhang N, Bevan MJ (2010) Dicer controls CD8+ T-cell activation, migration, and

survival. Proc Natl Acad Sci USA 107:21629–21634.

85. Chong MMW et al. (2010) Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev 24:1951–1960.

86. Brady BL, Steinel NC, Bassing CH (2010) Antigen Receptor Allelic Exclusion: An Update and Reappraisal. J Immunol 185:3801–3808.

87. Bolland DJ et al. (2004) Antisense intergenic transcription in V(D)J recombination. Nat Immunol 5:630–637.

Recombination and Is Controlled by the Intronic Enhancer E. Mol Cell Biol 27:5523– 5533.

89. Brady BL, Rupp LJ, Bassing CH (2013) Requirement for Dicer in Survival of Proliferating Thymocytes Experiencing DNA Double-Strand Breaks. J Immunol 190:3256–3266. 90. Strasser A, Harris AW, Cory S (1991) bcl-2 transgene inhibits T cell death and perturbs

thymic self-censorship. Cell 67:889–899.

91. Kirigin FF et al. (2012) Dynamic microRNA gene transcription and processing during T cell development. J Immunol 188:3257–3267.

92. Matloubian M et al. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355–360.

93. Zachariah MA, Cyster JG (2010) Neural Crest-Derived Pericytes Promote Egress of Mature Thymocytes at the Corticomedullary Junction. Science 328:1129–1135.

94. Pobezinsky LA et al. (2012) Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol 13:569–578.

95. Baaten BJG, Tinoco R, Chen AT, Bradley LM (2012) Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44. Front Immunol 3:23. 96. Goldrath AW (2002) Maintaining the status quo: T-cell homeostasis. Microbes Infect

4:539–545.

97. Linette GP, Li Y, Roth K, Korsmeyer SJ (1996) Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA

93:9545–9552.

98. Villunger A et al. (2004) Negative selection of semimature CD4+8-HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc Natl Acad Sci USA 101:7052–7057.

99. Reinhardt HC, Schumacher B (2012) The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet 28:128–136.

100. Zaidi SK et al. (2011) Bookmarking the Genome: Maintenance of Epigenetic Information.

J Biol Chem 286:18355–18361.

101. Koller BH, Marrack P, Kappler JW, Smithies O (1990) Normal development of mice deficient in β2M, MHC class I proteins, and CD8+ T cells. Science 248:1227–1230.

102. Linette GP et al. (1994) Bcl-2 is upregulated at the CD4+CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity

1:197–205.

103. Madsen L et al. (1999) Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci USA 96:10338–10343.

104. Hale JS, Boursalian TE, Turk GL, Fink PJ (2006) Thymic output in aged mice. Proc Natl Acad Sci USA 103:8447–8452.

105. Pear WS, Nolan GP, Scott ML, Baltimore D (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392–8396.

106. Telfer JC, Hedblom EE, Anderson MK, Laurent MN, Rothenberg EV (2004) Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J Immunol 172:4359–4370.

107. Devasthanam AS, Tomasi TB (2014) Dicer in immune cell development and function.

Immunol Invest 43:182–195.

108. Wei W et al. (2012) A Role for Small RNAs in DNA Double-Strand Break Repair. Cell

149:101–112.

109. Kaneko H et al. (2011) DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471:325–330.

110. Tarallo V et al. (2012) DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88. Cell 149:847–859.

111. Murchison EP, Partridge JF, Tam OH, Cheloufi S, Hannon GJ (2005) Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 102:12135–12140. 112. Henao-Mejia J et al. (2013) The microRNA miR-181 is a critical cellular metabolic

rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38:984–997.

113. Fedeli M et al. (2009) Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 183:2506–2512.

114. Suzuki A et al. (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14:523–534.

115. Cibotti R, Bhandoola A, Guinter TI, Sharrow SO, Singer A (2000) CD8 coreceptor extinction in signaled CD4+CD8+ thymocytes: coordinate roles for both transcriptional and posttranscriptional regulatory mechanisms in developing thymocytes. Mol Cell Biol

20:3852–3859.

116. Lewis BP, Burge CB, Bartel DP (2005) Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell

120:15–20.

117. Liu X, Jin D-Y, McManus MT, Mourelatos Z (2012) Precursor MicroRNA-Programmed Silencing Complex Assembly Pathways in Mammals. Mol Cell 46:507–517.

118. Buza-Vidas N et al. (2012) Dicer is selectively important for the earliest stages of erythroid development. Blood 120:2412–2416.

119. Shin K-J et al. (2006) A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA

103:13759–13764.

120. Swainson L, Mongellaz C, Adjali O, Vicente R, Taylor N (2008) Lentiviral transduction of immune cells. Methods Mol Biol 415:301–320.

121. Pannell D, Ellis J (2001) Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol 11:205–217.

122. Dervović D, Zúñiga-Pflücker JC (2010) Positive selection of T cells, an in vitro view.

Semin Immunol 22:276–286.

123. Mingueneau M et al. (2013) The transcriptional landscape of αβ T cell differentiation. Nat Immunol 14:619–632.

124. Ellmeier W, Haust L, Tschismarov R (2013) Transcriptional control of CD4 and CD8 coreceptor expression during T cell development. Cell Mol Life Sci 70:4537–4553. 125. Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T Cell Activation. Annu Rev Immunol

27:591–619.

126. Parel Y, Chizzolini C (2004) CD4+CD8+ double positive (DP) T cells in health and disease. Autoimmunity Reviews 3:215–220.

127. Kitchen SG et al. (2004) CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection. Proc Natl Acad Sci USA 101:8727–8732.

128. Storek J et al. (2008) Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Seminars in immunopathology 30:425–437.

129. Kalos M, June CH (2013) Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology. Immunity 39:49–60.

130. Lee PP et al. (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15:763–774.

131. Jonkers J et al. (2001) Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29:418–425.

132. Mombaerts P et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes.

Cell 68:869–877.

133. Hogquist KA et al. (1994) T cell receptor antagonist peptides induce positive selection.

Cell 76:17–27.

134. Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunology and Cell Biology 76:34–40.

135. Cadera EJ et al. (2009) NF-κB activity marks cells engaged in receptor editing. J Exp Med 206:1803–1816.

136. Bilic I et al. (2006) Negative regulation of CD8 expression via Cd8 enhancer–mediated recruitment of the zinc finger protein MAZR. Nat Immunol 7:392–400.

137. Pear WS et al. (1998) Efficient and rapid induction of a chronic myelogenous leukemia- like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.

Blood 92:3780–3792.

of high titer retroviral vectors. Nucleic Acids Res 23:628–633.

139. De Obaldia ME, Bell JJ, Bhandoola A (2013) Early T-cell progenitors are the major granulocyte precursors in the adult mouse thymus. Blood 121:64–71.

 

In document Médicos escritores latinoamericanos (página 68-70)